Greater Symptom Burden and Poorer Quality of Life Outcomes Are Associated With The Co-Occurrence of Anxiety and Depression During Cancer Chemotherapy
Clinicians need to perform comprehensive assessments of depression and anxiety and other common symptoms and QOL outcomes during chemotherapy. In addition, referrals for targeted interventions are needed to manage multiple symptoms and improve patients' QOL.
Authors
- Alejandra Calvo‐Schimmel
- Yvette P. Conley (ORCID: https://orcid.org/0000-0002-1784-6067)
- Carolyn Harris (ORCID: https://orcid.org/0000-0002-7080-4990)
- Joosun Shin (ORCID: https://orcid.org/0000-0001-6883-4448)
- Steven M. Paul (ORCID: https://orcid.org/0000-0002-3731-683X)
- Marilyn J. Hammer (ORCID: https://orcid.org/0000-0002-9561-6144)
- Bruce A. Cooper (ORCID: https://orcid.org/0000-0001-8932-4113)
- Lisa Morse (ORCID: https://orcid.org/0000-0001-9490-8906)
- Christine Miaskowski (ORCID: https://orcid.org/0000-0001-5170-2027)
- Jon D. Levine
Institutions
- American Cancer Society (US)
- University of Pittsburgh (US)
- University of California, San Francisco (US)
- Dana-Farber Cancer Institute (US)
Publication Details
- Journal
- Seminars in Oncology Nursing
- Published
- 2025-02-13
- DOI
- https://doi.org/10.1016/j.soncn.2025.151809
- Citations
- 2
- Primary Topic
- Cancer survivorship and care
- Type
- article
- Field-Weighted Citation Impact
- 2.09
Funders
- National Cancer Institute
- National Institute of Nursing Research